Revance Therapeutic (RVNC) PT Lowered to $11 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts RVNC Hot Sheet
Price: $3.65 --0%
Rating Summary:
4 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
4 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao lowered the price target on Revance Therapeutic (NASDAQ: RVNC) to $11.00 (from $12.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Nissan Chemical (4021:JP) PT Raised to JPY8,300 at Nomura/Instinet
- Resonac Holdings Corp (4004:JP) (SHWDY) PT Raised to JPY23,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
